Safety and efficacy of alirocumab: A meta analysis of 12 randomized controlled trials

BACKGROUND AND OBJECTIVE: Hypercholesterolemia is one of the major risk factor for atherosclerotic coronary heart disease, especially coronary heart disease. Most effective class of medications for prevention of cardiovascular events and LDL-C reduction are the statins. Approximately only one fourth...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Ajay K., Mehani, Rekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691459/
https://www.ncbi.nlm.nih.gov/pubmed/31463238
http://dx.doi.org/10.4103/jfmpc.jfmpc_406_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691459/
https://www.ncbi.nlm.nih.gov/pubmed/31463238
http://dx.doi.org/10.4103/jfmpc.jfmpc_406_19

Ejemplares similares